Table 4.

Cholesterol, glucose, HbA1c, waist and hip circumference, and SF-12 and IWQOL-Lite outcome

	Screening	Wk 0	Wk 13	Wk 26	Wk 52	p
Triglycerides	1.33 ± 0.13	1.26 ± 0.16	1.40 ± 0.20	1.22 ± 0.14	1.38 ± 0.16	0.75
HDL	1.20 ± 0.07	1.23 ± 0.09	1.24 ± 0.09	1.33 ± 0.10	1.34 ± 0.10	0.08
LDL	3.04 ± 0.19	3.13 ± 0.19	3.04 ± 0.16	3.03 ± 0.18	3.21 ± 0.20	0.85
Total cholesterol	4.84 ± 0.22	4.88 ± 0.24	4.88 ± 0.22	4.88 ± 0.21	5.10 ± 0.27	0.75
Fasting glucose	5.54 ± 0.19	5.45 ± 0.16	5.64 ± 0.18	5.42 ± 0.19	5.45 ± 0.20	0.33
HbA1c	5.60 ± 0.10	5.43 ± 0.07	5.48 ± 0.07	5.45 ± 0.07	5.50 ± 0.11	0.35
Waist circumference	122.4 ± 3.2	114.1 ± 5.1	115.9 ± 3.0	114.6 ± 3.4	118.7 ± 3.2	0.08
Hip circumference	131.3 ± 1.9	122.9 ± 4.8	125.5 ± 1.9	125.8 ± 2.2	127.8 ± 1.7	0.1
SF-12 PCS	41.3 ± 1.9	44.4 ± 2.0	46.6 ± 1.7*	45.5 ± 1.7	46.6 ± 1.9*	< 0.001
SF-12 MCS	53.5 ± 2.8	56.4 ± 2.7	55.7 ± 2.4	58.4 ± 1.8	56.6 ± 2.7	0.40
IWQOL-Lite total score	55.4 ± 3.8	67.8 ± 3.7**	70.8 ± 3.4**	74.0 ± 3.7**	75.0 ± 3.4**	< 0.001

All data are presented as mean ± SEM. P values are for test day effects determined by mixed analysis of variance model. Significant differences were determined by using post hoc comparisons with Bonferroni’s correction. Wk 0: week 0, Wk 13: week 13, Wk 26: week 26, Wk 52: week 52

*Significantly different from screening, p < 0.05

88 significantly different from screening, p < 0.001